Involvement of DDAH/ADMA pathway in the pathogenesis of rheumatoid arthritis in rats

International Immunopharmacology

Volumn 16, Issue 2, 2013, Pages 322-331

  Chen, Xu Meng ^a   Xia, Jing ^a   Zhou, Ting ^a   Yuan, Qiong ^a   Zhang, Wei Fang ^a   Hu, Chang Ping ^a   Li, Yuan Jian ^a   Jiang, Jun Lin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Cortistatin; Dimethylarginine dimethylohydrolase; Inflammation; Rheumatoid arthritis

Indexed keywords

CORTISTATIN; DIMETHYLARGININE DIMETHYLOHYDROLASE 2; ENZYME; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING;

AMIDOHYDROLASES; ANIMALS; ANKLE JOINT; ARGININE; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYTOKINES; MALE; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE;

EID: 84878291000     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.04.009     Document Type: Article

References (31)

1. A. Sandoo, J.J. Veldhuijzen van Zanten, G.S. Metsios, D. Carroll, and G.D. Kitas Vascular function and morphology in rheumatoid arthritis: a systematic review Rheumatology (Oxford) 50 2011 2125 2139
2. F. Khan, B. Galarraga, and J.J. Belch The role of endothelial function and its assessment in rheumatoid arthritis Nat Rev Rheumatol 6 2010 253 261
3. F. Montecucco, and F. Mach Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis Rheumatology (Oxford) 48 2009 11 22
4. S.K. Agarwal Biologic agents in rheumatoid arthritis: an update for managed care professionals J Manag Care Pharm 17 2011 S14 S18
5. A. Szuba, and M. Podgorski Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor - evidence from epidemiological and prospective clinical trials Pharmacol Rep 58 2006 16 20 [Suppl.]
6. T. Dimitroulas, A. Sandoo, and G.D. Kitas Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases Int J Mol Sci 13 2012 12315 12335
7. M. Di Franco, F.R. Spinelli, A. Metere, M.C. Gerardi, V. Conti, and F. Boccalini Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis Mediators Inflamm 2012 2012 347268
8. A. Surdacki, J. Martens-Lobenhoffer, A. Wloch, E. Marewicz, T. Rakowski, and E. Wieczorek-Surdacka Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis Arthritis Rheum 56 2007 809 819 (Pubitemid 46399428)
9. M. Turiel, F. Atzeni, L. Tomasoni, S. de Portu, L. Delfino, and B.D. Bodini Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients Rheumatology (Oxford) 48 2009 834 839
10. A. Surdacki, J. Martens-Lobenhoffer, A. Wloch, P. Gluszko, T. Rakowski, and J.S. Dubiel Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration Metabolism 58 2009 316 318
11. M.F. Chen, X.M. Xie, T.L. Yang, Y.J. Wang, X.H. Zhang, and B.L. Luo Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II J Vasc Res 44 2007 391 402
12. M. Siervo, M. Corander, S. Stranges, and L. Bluck Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA) Nutr Metab Cardiovasc Dis 21 2011 1 10
13. C. Antoniades, M. Demosthenous, D. Tousoulis, A.S. Antonopoulos, C. Vlachopoulos, and M. Toutouza Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis Hypertension 58 2011 93 98
14. A. Ito, P.S. Tsao, S. Adimoolam, M. Kimoto, T. Oqawa, and J.P. Cooke Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase Circulation 24 1999 3092 3095 (Pubitemid 29289071)
15. T. Ogawa, M. Kimoto, and K. Sasaoka Purification and properties of a new enzyme, NG, NG-dimethylarginine dimethylaminohydrolase, from rat kidney J Biol Chem 264 1989 10205 10209 (Pubitemid 19159295)
16. C.T. Tran, M.F. Fox, P. Vallance, and J.M. Leiper Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins Genomics 68 2000 101 105
17. J. Beltowski, and A. Kedra Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy Pharmacol Rep 58 2006 159 178
18. A.D. Spier, and L. de Lecea Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions Brain Res Brain Res Rev 33 2000 228 241
19. D. Ferone, M. Boschetti, E. Resmini, M. Giusti, V. Albanese, and U. Goglia Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system Ann N Y Acad Sci 1069 2006 129 144 (Pubitemid 43989856)
20. E. Gonzalez-Rey, A. Chorny, G. Robledo, and M. Delgado Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia J Exp Med 203 2006 563 571
21. E. Gonzalez-Rey, N. Varela, A.F. Sheibanie, A. Chorny, D. Ganea, and M. Delgado Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease Proc Natl Acad Sci U S A 103 2006 4228 4233
22. A. Rubio, J. Avila, and L. de Lecea Cortistatin as a therapeutic target in inflammation Expert Opin Ther Targets 11 2007 1 9 (Pubitemid 46099749)
23. M. Delgado, and D. Ganea Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents Brain Behav Immun 22 2008 1146 1151
24. E. Gonzalez-Rey, A. Chorny, R.G. Del Moral, N. Varela, and M. Delgado Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses Ann Rheum Dis 66 2007 582 588 (Pubitemid 46707125)
25. M. Yang, C. Xiao, Q. Wu, M. Niu, Q. Yao, and K. Li Anti-inflammatory effect of Sanshuibaihu decoction may be associated with nuclear factor-kappa B and p38 MAPK alpha in collagen-induced arthritis in rat J Ethnopharmacol 127 2010 264 273
26. Q. Yuan, D.J. Jiang, Q.Q. Chen, S. Wang, H.Y. Xin, and H.W. Deng Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells Biochem Biophys Res Commun 356 2007 880 885 (Pubitemid 46529375)
27. H. Miyazaki, H. Matsuoka, J.P. Cooke, M. Usui, S. Ueda, and S. Okuda Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis Circulation 99 1999 1141 1146 (Pubitemid 29120084)
28. L.J. Millatt, G.S. Whitley, D. Li, J.M. Leiper, H.M. Siragy, and R.M. Carey Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension Circulation 108 2003 1493 1498 (Pubitemid 37176457)
29. D.A. Pappas, L. Geraldino-Pardilla, and J.M. Bathon Immune modulation of rheumatoid arthritis Best Pract Res Clin Rheumatol 25 2011 873 889
30. M. Khoury, V. Escriou, G. Courties, A. Galy, R. Yao, and C. Largeau Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes Arthritis Rheum 58 2008 2356 2367
31. M. Cugno, F. Ingegnoli, R. Gualtierotti, and F. Fantini Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis Curr Vasc Pharmacol 8 2010 285 292